Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Rectal Neoplasms 1Meningioma 1Lymphoma, Mantle-Cell 1Leukemia, Myeloid, Acute 1Genetic Diseases, Inborn 1

Interventions

Letrozole 27Fulvestrant 27Specimen Handling 24ribociclib 17pembrolizumab 16exemestane 16Paclitaxel 16Carboplatin 16Capecitabine 16Anastrozole 16Magnetic Resonance Spectroscopy 15palbociclib 14Tamoxifen 13trastuzumab deruxtecan 12Trastuzumab 12Biopsy 11abemaciclib 10Cyclophosphamide 10pertuzumab 8Radiotherapy 8elacestrant 7sacituzumab govitecan 6patritumab deruxtecan 6olaparib 6inavolisib 6giredestrant 6Surveys and Questionnaires 6Radiation 6eribulin 5Standard of Care 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Tablets × 30 days × Clear all
NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting
130 enrolled
Breast

Breast Neoplasms, Genetic Diseases, Inborn

NCT04055493 2026-05-11

ADAPTcycle

West German Study Group

Phase 3 Active not recruiting
1,684 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡